NR1H4 and metabolic dysfunction-associated steatohepatitis: The second ranked articles are ‘The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids’ published in HEPATOLOGY in 2018 and ‘Farnesoid X nuclear receptor ligand obeticholic acid for non‐cirrhotic, nonalcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo‐controlled trial’ published in LANCET in 2015.18, 23